4,875
+2.09%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About InBioGen Co
Its shares trade on KRX under the ticker 101140.KS. It has been listed since 2 April 2008. In the fiscal year to 31 December 2025, it reported revenue of ₩6.30bn and a net loss of ₩1.42bn. At that date it held total assets of ₩159.99bn and shareholders' equity of ₩157.64bn.
INBIOGEN CO., Ltd. engages in the manufacture and sale of footwear products. The company is headquartered in Seoul, Seoul. The company went IPO on 2008-04-02. The firm operates its business through four segments. The Kiosk Business segment is engaged in the operation of unmanned payment machine business in restaurants, karaoke rooms, and personal computer (PC) rooms. The Footwear Business segment is mainly engaged in the sale of children's shoes and adult shoes. The Wood Pellet Business segment mainly sells wood pellets and sawdust. The Other Business segment engages in online and offline education business to foster human resources in the FinTech service, platform business, and block chain industry.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Discretionary
- Industry
- Textiles, Apparel & Luxury Goods
- Listed since
- 2 Apr 2008
- Employees
- 36
- Website
- inbiogen.co.kr ↗
Leadership
Pay as last reported
- Sang Jun LeeChief Executive Officer, Director, since 2019
- Tae Jeong HaVice President, Director, since 2010
- Jong Hwan KimVice President, Director
- Seong Yeop JungVice President
- Sang Yeong WonManaging Director, since 2023
- Yeong Hun GwonInternal Auditor
- Seong Man HwangInternal Auditor
- Mr. Ji Yeon KangDirector
- Byeong Ho LeeDirector
- Gyeong Yeol LeeDirector
- Sang Gil LeeDirector
- Yeong Seo ParkDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- InBioGen's Footwear Business segment sells children's and adult shoes in South Korea.
- The Kiosk Business segment operates unmanned payment machines in restaurants and karaoke rooms.
- The Wood Pellet Business segment supplies wood pellets and sawdust to local markets.
Weaknesses
- InBioGen's Wood Pellet Business segment has limited market reach in South Korea.
- The company's small employee count of 36 restricts operational capacity.
- The Other Business segment's FinTech education services face low market penetration.
Opportunities
- Expanding the Footwear Business segment into international markets could increase revenue.
- The Kiosk Business segment can integrate with more restaurant chains for growth.
- The Wood Pellet Business segment may benefit from rising demand for sustainable materials.
Threats
- Competition from larger footwear manufacturers in South Korea poses a risk.
- The Kiosk Business segment faces regulatory challenges in payment machine operations.
- The Other Business segment's FinTech education services are vulnerable to market volatility.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.